Humanized CAR-T Cells of Anti-BCAM and Anti-CD19 Against Relapsed and Refractory Multiple Myeloma
Clinical trial NCT04194931 · UNKNOWN
Trial details
- NCT number
- NCT04194931
- Sponsor
- The First Affiliated Hospital of Nanchang University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-01
- Primary completion
- 2020-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.